C
RNAC
Cartesian
6.24
-0.02-0.32%After Hours: 6.61 +0.37 +5.93%19:44 04/06 EDT
OPEN/PREV CLOSE6.55/6.28
TODAY RANGE6.03-6.57
VOL152.53K
MARKET CAP163.03M
52 WEEK RANGE5.60-15.57
AVG VOL (3M)178.16K
% TURNOVER0.58%
TURNOVER--
P/E (TTM)-1.2259
% RANGE8.60%
EPS(TTM)-5.0168
P/E(FORWARD)-1.7472
P/B-1.2672
BVPS-4.8533
DIVIDEND--
P/S57.21
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP65.80M
SHARES OUTSTANDING26.51M
NEXT EARNINGS05/06-05/11
FREE FLOAT10.70M
LOT SIZE1
EX-DATE04/05/2024
News
Press Releases
Financial Reports
Profile
TipRanks·03/30 22:46
Cartesian Therapeutics Announces Board Member Murat Kalayoglu Resignation
Reuters·03/30 21:48
Cartesian Therapeutics director Murat Kalayoglu resigns, effective March 31
TipRanks·03/10 13:05
Wedbush Reaffirms Their Buy Rating on Cartesian Therapeutics (RNAC)
Dow Jones·03/10 12:33
Cartesian Therapeutics Price Target Maintained With a $38.00/Share by Wedbush
NASDAQ·03/10 00:03
Cantor Fitzgerald Upgrades Cartesian Therapeutics (RNAC)
Dow Jones·03/09 17:51
Cartesian Therapeutics Stock Gains on Full-Year Revenue Beat
Dow Jones·03/09 17:04
Cartesian Therapeutics Raised to Overweight From Neutral by Cantor Fitzgerald
Dow Jones·03/09 17:04
Cartesian Therapeutics Price Target Announced at $16.00/Share by Cantor Fitzgerald
Same Industry
Name/Symbol
Change%
Price